Natural history and long-term effects of variant protein reduction in non-V30M ATTR amyloidosis

Taro Yamashita1, Mitsuharu Ueda2, Toshiya Nomura2

  • 1From the Department of Neurology (T.Y., M.U., T.N., T.O., M.O., Y.T., Y. Inoue, T.M., Y.M., K.T., Y.A.), Graduate School of Medical Sciences, Kumamoto University; Amyloidosis Medical Practice Center (T.Y.), Kumamoto University Hospital; Department of Morphological and Physiological Sciences (K.O., T.H.), Graduate School of Medical Sciences, Kumamoto University; and Department of Transplantation and Pediatric Surgery (Y. Inomata), Graduate School of Medical Sciences, Kumamoto University, Japan. taro-yamashita@kuh.kumamoto-u.ac.jp.

Neurology
|September 29, 2019
PubMed
Abstract

No abstract available in PubMed .